N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid(96920-07-9)
- Name: N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid
- Synonyms:2-Butenoicacid, 4-[(2-amino-2-carboxyethyl)amino]-4-oxo-, 1-methyl ester, [S-(E)]-
- Molecular Formula:C8H12 N2 O5
- Molecular Weight:216.194
- CAS Registry Number:96920-07-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.96920-07-9 N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.96920-07-9 2-Butenoic acid, 4-[[(2S)-2-amino-2-carboxyethyl]amino]-4-oxo-, 1-methyl ester, (2E)-
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.96920-07-9 N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 154334-72-2/(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R)-1-hydroxy-2-methyl-propyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecon
- 40428-33-9/2H-1-Benzothiopyran-2-one,3,4-dihydro-
- 181-46-4/hexahydro-1,1-hexamethylene-
- 20055-60-1/2-methyl-1-phenyl-propan-2-ol
- 112963-09-4/Benzenemethanol, alpha-(((3-(1H-benimidazol-1-yl)-1,1-dimethylpropyl)amino)methyl)-2-fluoro-4-hydroxy-, formate (salt), mixt. contg.
- 85150-36-3/TAB antidote
- 113712-92-8/Benzenesulfonamide, 4-amino-N-(aminocarbonyl)-, compd. with 2,2-iminobis(ethanol) (1:1)
- 302-31-8/morphine tartrate
- 27867-40-9/2-Hexanone,6-(trihydroxysilyl)-
- 9007-97-0/Gutta-percha
- 7403-97-6/5-(3-methylbutyl)-5-(tetrahydro-2H-pyran-4-yl)imidazolidine-2,4-dione
- 68606-12-2/Glycerides, C8-18 and C18-unsatd. mono- and di-, ethoxylated
- 78039-66-4/20-ethyl-7,8-dihydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl 2-methylbutanoate
- 51064-65-4/(+)-1,4-Di-o-tosyl-2,3-o-isopropylidene-d-threitol
- 4537-15-9/BENZENE,(1-BUTYLHEPTYL)-
- 6633-52-9/2-(4-bromo-2-chlorophenoxy)-N-(3,4-dimethylphenyl)acetamide
- 39246-63-4/Spiro[isoquinoline-2,7'-[6]thia[7]azabicyclo[3.2.1]-octa[1,3,5(8)]triene]
- 40771-33-3/5-chloro-2-{[6-(1,3-thiazolidin-3-yl)hexyl]oxy}pyridine hydrochloride (1:1)
- 145107-58-0/1H,9H-4,10-Dioxacyclobut[3,4]indeno[5,6-a]naphthalen-9-one,1a,2,3,3a,10c,10d-hexahydro-6-hydroxy-1,1,3a-trimethyl-, (1aR,3aS,10cS,10dS)-(9CI)
- 96920-07-9/N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid
- 1161-08-6/BIS(2,4-DICHLOROPHENYL)OXALATE
- 10476-87-6/STRYCHNINE CACODYLATE
- 72506-76-4/(2E)-3-[(11R,11aS)-9-hydroxy-11-methoxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl]prop-2-enenitrile
- 60461-84-9/4-(2-aminoethoxy)-4-oxobut-2-enoic acid
- 3934-84-7/3,4-DIHYDROXY-5-METHOXYBENZOIC ACID
- 15000-41-6/3-benzyl-2-hydroxyquinolin-4(1H)-one
- 67893-20-3/2-Propenoic acid, butyl ester, polymer with ethenyl acetate, 2-ethylhexyl 2-propenoate, 2-propenenitrile and N-(1,1,3,3-tetramethylbutyl)-2-propenamide
- 92528-04-6/N-[3-(4-chlorophenyl)-3-oxopropyl]-N-methylglycine
- 141358-48-7/Dammar-24-en-19-al,3-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-20-[(6-O-b-D-xylopyranosyl-b-D-glucopyranosyl)oxy]-, (3b)- (9CI)
- 5917-61-3/BIS-(2,2-DINITROPROPYL)FORMAL